This model is characterized by a genetic mutation in the leptin receptor, leading to hyperglycemia, obesity, hyperinsulinemia, hyperlipidemia, and impaired glucose tolerance [18,19]. This evidence concerns the gene LEPR and Hyperinsulinemia.